The Ohio Third Frontier Commission, a state economic development initiative, recently approved more than $12.8 million in funds to promote cutting-edge biotechnology, including a neurostimulation device to enhance breathing and a spine fusion medical device. The money included Ohio Third Frontier Commercial Acceleration Loan Fund awards to help for-profit companies commercialize their technologies: Synapse Biomedical, of Oberlin, OH, received a nearly $2.4 million loan to bring its NeuRx Diaphragm Pacing System platform to a new regulatory approval.
Help employers find you! Check out all the jobs and post your resume.
